Thus, the content of cell-released EVs may serve as a biomarker that defines the stage of CRC and either Snail, or the different microRNAs that is carried by EVs to the destination sites, which serves as a pre-metastatic niche, may be a target to prevent cancer progression. The gene discussed is SNAI1; the disease is cancer.